Sinusitis (acute): antimicrobial prescribing | NG79 | | |
Cataracts in adults: management | NG77 | | |
Cystic fibrosis: diagnosis and management | NG78 | | |
Hepatitis B (chronic): diagnosis and management | CG165 | | |
Tofacitinib for moderate to severe rheumatoid arthritis | TA480 | | |
Immunosuppressive therapy for kidney transplant in adults | TA481 | | |
Immunosuppressive therapy for kidney transplant in children and young people | TA482 | | |
Child maltreatment: when to suspect maltreatment in under 18s | CG89 | | |
Child abuse and neglect | NG76 | | |
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee | TA477 | | |
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma | TA478 | | |
Reslizumab for treating severe eosinophilic asthma | TA479 | | |
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone disease | IPG593 | | |
Faltering growth: recognition and management of faltering growth in children | NG75 | | |
Cetuximab and panitumumab for previously untreated metastatic colorectal cancer | TA439 | | |
Intermediate care including reablement | NG74 | | |
Ab externo canaloplasty for primary open-angle glaucoma | IPG591 | | |
High-intensity focused ultrasound for symptomatic breast fibroadenoma | IPG592 | | |
Pembrolizumab for advanced melanoma not previously treated with ipilimumab | TA366 | | |
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy | TA428 | | |
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab | TA357 | | |
Fertility problems: assessment and treatment | CG156 | | |
Sorafenib for treating advanced hepatocellular carcinoma | TA474 | | |
Dimethyl fumarate for treating moderate to severe plaque psoriasis | TA475 | | |
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer | TA476 | | |
Psoriasis: assessment and management | CG153 | | |
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck | TA473 | | |
Vitamin D: supplement use in specific population groups | PH56 | | |
Radiofrequency treatment for haemorrhoids | IPG589 | | |
Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal) | TA468 | | |
Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal) | TA469 | | |
Advanced breast cancer: diagnosis and treatment | CG81 | | |
Holoclar for treating limbal stem cell deficiency after eye burns | TA467 | | |
Pemetrexed for the maintenance treatment of non-small-cell lung cancer | TA190 | | |
Developmental follow-up of children and young people born preterm | NG72 | | |
Cabozantinib for previously treated advanced renal cell carcinoma | TA463 | | |
Baricitinib for moderate to severe rheumatoid arthritis | TA466 | | |
moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment | MTG2 | | |
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | CG32 | | |
Transcatheter aortic valve implantation for aortic stenosis | IPG586 | | |
Adalimumab and dexamethasone for treating non-infectious uveitis | TA460 | | |
Roflumilast for treating chronic obstructive pulmonary disease | TA461 | | |
Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma | TA462 | | |
Parkinson's disease in adults | NG71 | | |
Constipation in children and young people: diagnosis and management | CG99 | | |
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people | TA455 | | |
Ustekinumab for moderately to severely active Crohn's disease after previous treatment | TA456 | | |
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners | DG3 | | |
Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal) | TA452 | | |
Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal) | TA453 | | |
Daratumumab with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA454 | | |
Eliglustat for treating type 1 Gaucher disease | HST5 | | |
Infracoccygeal sacropexy using mesh to repair vaginal vault prolapse | IPG581 | | |
Infracoccygeal sacropexy using mesh to repair uterine prolapse | IPG582 | | |
Sacrocolpopexy using mesh to repair vaginal vault prolapse | IPG583 | | |
Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse | IPG584 | | |
Etelcalcetide for treating secondary hyperparathyroidism | TA448 | | |
Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease | TA449 | | |
Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemia | TA450 | | |
Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia | TA451 | | |
Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | DG29 | | |
Spondyloarthritis in over 16s: diagnosis and management | NG65 | | |
Endoscopic full thickness removal of non-lifting colonic polyps | IPG580 | | |
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal) | TA444 | | |
Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs | TA445 | | |
Idiopathic pulmonary fibrosis in adults: diagnosis and management | CG163 | | |
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy | DG28 | | |
Intravenous fluid therapy in adults in hospital | CG174 | | |
Irreversible electroporation for treating pancreatic cancer | IPG579 | | |
Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine | TA440 | | |
Ixekizumab for treating moderate to severe plaque psoriasis | TA442 | | |
Obeticholic acid for treating primary biliary cholangitis | TA443 | | |
Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
Alcohol-use disorders: diagnosis and management of physical complications | CG100 | | |
Minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac pain | IPG578 | | |
Irritable bowel syndrome in adults: diagnosis and management | CG61 | | |
Managing medicines for adults receiving social care in the community | NG67 | | |
Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) | TA240 | | |
Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal) | TA438 | | |
Patient group directions | MPG2 | | |
Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women | IPG576 | | |
Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse | IPG577 | | |
Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal) | TA436 | | |
Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal) | TA437 | | |
Elotuzumab for previously treated multiple myeloma (terminated appraisal) | TA434 | | |
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) | TA435 | | |
Mental health of adults in contact with the criminal justice system | NG66 | | |
Ustekinumab for treating active psoriatic arthritis | TA340 | | |
Ustekinumab for the treatment of adults with moderate to severe psoriasis | TA180 | | |
Molecular testing strategies for Lynch syndrome in people with colorectal cancer | DG27 | | |
Migalastat for treating Fabry disease | HST4 | | |
Lateral interbody fusion in the lumbar spine for low back pain | IPG574 | | |
Trabecular stent bypass microsurgery for open-angle glaucoma | IPG575 | | |
Everolimus for advanced renal cell carcinoma after previous treatment | TA432 | | |
Apremilast for treating active psoriatic arthritis | TA433 | | |
Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
HumiGard for preventing inadvertent perioperative hypothermia | MTG31 | | |
Osteoporosis: assessing the risk of fragility fracture | CG146 | | |
Cerebral palsy in under 25s: assessment and management | NG62 | | |
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation | TA429 | | |
Sofosbuvir–velpatasvir for treating chronic hepatitis C | TA430 | | |
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib | TA427 | | |
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation | CG135 | | |
Extracorporeal shockwave therapy for Achilles tendinopathy | IPG571 | | |
Radiation therapy for early Dupuytren's disease | IPG573 | | |
Everolimus with exemestane for treating advanced breast cancer after endocrine therapy | TA421 | | |
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA422 | | |
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens | TA423 | | |
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer | TA424 | | |
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia | TA425 | | |
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia | TA426 | | |
Hypothermia: prevention and management in adults having surgery | CG65 | | |
Epiduroscopic lumbar discectomy through the sacral hiatus for sciatica | IPG570 | | |
Ticagrelor for preventing atherothrombotic events after myocardial infarction | TA420 | | |
XprESS multi sinus dilation system for treating chronic sinusitis | MTG30 | | |
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis | CG95 | | |
Coexisting severe mental illness and substance misuse: community health and social care services | NG58 | | |
Spasticity in under 19s: management | CG145 | | |
Endoscopic transluminal pancreatic necrosectomy | IPG567 | | |
Percutaneous insertion of craniocaudal expandable implants for vertebral compression fracture | IPG568 | | |
Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity | IPG569 | | |
Dapagliflozin in combination therapy for treating type 2 diabetes | TA288 | | |
Nivolumab for previously treated advanced renal cell carcinoma | TA417 | | |
Dapagliflozin in triple therapy for treating type 2 diabetes | TA418 | | |
Apremilast for treating moderate to severe plaque psoriasis | TA419 | | |
High-throughput non-invasive prenatal testing for fetal RHD genotype | DG25 | | |
Physical health of people in prison | NG57 | | |
Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor | TA415 | | |
Elbasvir–grazoprevir for treating chronic hepatitis C | TA413 | | |
Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma | TA414 | | |
Single-incision short sling mesh insertion for stress urinary incontinence in women | IPG566 | | |
Miniature lens system implantation for advanced age-related macular degeneration | IPG565 | | |
Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer | TA411 | | |
Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases | TA412 | | |
Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA406 | | |
Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors | TA407 | | |
Pegaspargase for treating acute lymphoblastic leukaemia | TA408 | | |
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion | TA409 | | |
Talimogene laherparepvec for treating unresectable metastatic melanoma | TA410 | | |
Multimorbidity: clinical assessment and management | NG56 | | |
Harmful sexual behaviour among children and young people | NG55 | | |
Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
Transition between inpatient mental health settings and community or care home settings | NG53 | | |
Stable angina: management | CG126 | | |
Acute upper gastrointestinal bleeding in over 16s: management | CG141 | | |
Bosutinib for previously treated chronic myeloid leukaemia | TA401 | | |
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin | TA402 | | |
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer | TA403 | | |
Degarelix for treating advanced hormone-dependent prostate cancer | TA404 | | |
Trifluridine–tipiracil for previously treated metastatic colorectal cancer | TA405 | | |
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel | TA391 | | |
Palliative care for adults: strong opioids for pain relief | CG140 | | |
Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation | IPG563 | | |
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen | TA259 | | |
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation | TA398 | | |
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts | TA399 | | |
Nivolumab in combination with ipilimumab for treating advanced melanoma | TA400 | | |
Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated | TA387 | | |
Non-Hodgkin's lymphoma: diagnosis and management | NG52 | | |
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | CG64 | | |
Non-alcoholic fatty liver disease (NAFLD): assessment and management | NG49 | | |
Oral health for adults in care homes | NG48 | | |
Microstructural scaffold (patch) insertion without autologous cell implantation for repairing symptomatic chondral knee defects | IPG560 | | |
Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting | IPG561 | | |
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules | IPG562 | | |
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA393 | | |
Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA394 | | |
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer | TA395 | | |
Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma | TA396 | | |
Adalimumab for treating moderate to severe hidradenitis suppurativa | TA392 | | |
Endovenous mechanochemical ablation for varicose veins | IPG557 | | |
Haematological cancers: improving outcomes | NG47 | | |
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes | TA390 | | |
ImmunoCAP ISAC 112 for multiplex allergen testing | DG24 | | |
Microwave ablation for treating liver metastases | IPG553 | | |
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension | IPG554 | | |
Percutaneous interlaminar endoscopic lumbar discectomy for sciatica | IPG555 | | |
Percutaneous transforaminal endoscopic lumbar discectomy for sciatica | IPG556 | | |
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction | TA388 | | |
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer | TA389 | | |
Controlled drugs: safe use and management | NG46 | | |
Routine preoperative tests for elective surgery | NG45 | | |
Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis | IPG551 | | |
Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine | IPG552 | | |
Endoscopic carbon dioxide laser cricopharyngeal myotomy for relief of oropharyngeal dysphagia | IPG550 | | |
Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis | TA386 | | |
Community engagement: improving health and wellbeing and reducing health inequalities | NG44 | | |
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) | TA23 | | |
Spectra Optia for automatic red blood cell exchange in people with sickle cell disease | MTG28 | | |
Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction | IPG546 | | |
Mechanical clot retrieval for treating acute ischaemic stroke | IPG548 | | |
Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death | IPG549 | | |
Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia | TA385 | | |
Transition from children's to adults' services for young people using health or social care services | NG43 | | |
Nivolumab for treating advanced (unresectable or metastatic) melanoma | TA384 | | |
Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) | DG22 | | |
Fractures (non-complex): assessment and management | NG38 | | |
Major trauma: assessment and initial management | NG39 | | |
Major trauma: service delivery | NG40 | | |
Spinal injury: assessment and initial management | NG41 | | |
Sunlight exposure: risks and benefits | NG34 | | |
TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis | TA383 | | |
Percutaneous coblation of the intervertebral disc for low back pain and sciatica | IPG543 | | |
Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica | IPG544 | | |
Percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain | IPG545 | | |
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated | TA377 | | |
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy | TA378 | | |
Nintedanib for treating idiopathic pulmonary fibrosis | TA379 | | |
Panobinostat for treating multiple myeloma after at least 2 previous treatments | TA380 | | |
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal) | TA382 | | |
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed | TA375 | | |
Guidance on the use of imatinib for chronic myeloid leukaemia | TA70 | | |
Older people: independence and mental wellbeing | NG32 | | |
Repetitive transcranial magnetic stimulation for depression | IPG542 | | |
Joint distraction for ankle osteoarthritis | IPG538 | | |
Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma | IPG539 | | |
Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease | IPG540 | | |
Insertion of a subretinal prosthesis system for retinitis pigmentosa | IPG537 | | |
Care of dying adults in the last days of life | NG31 | | |
Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears | TA369 | | |
Bortezomib for previously untreated mantle cell lymphoma | TA370 | | |
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis | TA373 | | |
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy | TA374 | | |
Transition between inpatient hospital settings and community or care home settings for adults with social care needs | NG27 | | |
Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes | IPG534 | | |
Living-donor liver transplantation | IPG535 | | |
Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention | IPG536 | | |
Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care | NG26 | | |
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C | TA365 | | |
Vortioxetine for treating major depressive episodes | TA367 | | |
Ledipasvir–sofosbuvir for treating chronic hepatitis C | TA363 | | |
Blood transfusion | NG24 | | |
VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions | DG19 | | |
Older people with social care needs and multiple long-term conditions | NG22 | | |
Implanting a baroreceptor stimulation device for resistant hypertension | IPG533 | | |
Developing and updating local formularies | MPG1 | | |
Tolvaptan for treating autosomal dominant polycystic kidney disease | TA358 | | |
Idelalisib for treating chronic lymphocytic leukaemia | TA359 | | |
Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal) | TA362 | | |
Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) | DG18 | | |
Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer | IPG532 | | |
Home care: delivering personal care and practical support to older people living in their own homes | NG21 | | |
Coeliac disease: recognition, assessment and management | NG20 | | |
Preoperative high dose rate brachytherapy for rectal cancer | IPG531 | | |
Transcranial direct current stimulation (tDCS) for depression | IPG530 | | |
Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy | TA352 | | |
Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal) | TA353 | | |
Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism | TA354 | | |
Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use | NG15 | | |
Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section | IPG528 | | |
Joint distraction for knee osteoarthritis without alignment correction | IPG529 | | |
Naloxegol for treating opioid‑induced constipation | TA345 | | |
Aflibercept for treating diabetic macular oedema | TA346 | | |
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer | TA347 | | |
Everolimus for preventing organ rejection in liver transplantation | TA348 | | |
Secukinumab for treating moderate to severe plaque psoriasis | TA350 | | |
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) | TA351 | | |
Suture fixation of acute disruption of the distal tibiofibular syndesmosis | IPG521 | | |
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis | IPG523 | | |
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism | IPG524 | | |
Electrotherapy for the treatment of haemorrhoids | IPG525 | | |
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache | IPG527 | | |
Insertion of an epiretinal prosthesis for retinitis pigmentosa | IPG519 | | |
Radiofrequency ablation for gastric antral vascular ectasia | IPG520 | | |
Omalizumab for previously treated chronic spontaneous urticaria | TA339 | | |
Vedolizumab for treating moderately to severely active ulcerative colitis | TA342 | | |
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism | TA341 | | |
Lower urinary tract symptoms in men: management | CG97 | | |
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia | TA343 | | |
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges | NG11 | | |
Violence and aggression: short-term management in mental health, health and community settings | NG10 | | |
Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section | IPG515 | | |
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation | IPG516 | | |
Insertion of endobronchial nitinol coils to improve lung function in emphysema | IPG517 | | |
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes | IPG518 | | |
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome | TA335 | | |
Empagliflozin in combination therapy for treating type 2 diabetes | TA336 | | |
Rifaximin for preventing episodes of overt hepatic encephalopathy | TA337 | | |
Obesity prevention | CG43 | | |
Excess winter deaths and illness and the health risks associated with cold homes | NG6 | | |
Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | NG5 | | |
VibraTip for testing vibration perception to detect diabetic peripheral neuropathy | MTG22 | | |
Safe midwifery staffing for maternity settings | NG4 | | |
Bladder cancer: diagnosis and management | NG2 | | |
Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy | TA329 | | |
Sofosbuvir for treating chronic hepatitis C | TA330 | | |
Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment | TA333 | | |
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal) | TA334 | | |
Flexible endoscopic treatment of a pharyngeal pouch | IPG513 | | |
Eculizumab for treating atypical haemolytic uraemic syndrome | HST1 | | |
Implantation of a shock or load absorber for mild to moderate symptomatic medial knee osteoarthritis | IPG512 | | |
Open reduction of slipped capital femoral epiphysis | IPG511 | | |
Hysteroscopic metroplasty of a uterine septum for primary infertility | IPG509 | | |
Hysteroscopic metroplasty of a uterine septum for recurrent miscarriage | IPG510 | | |
Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma | TA269 | | |
Single‑incision laparoscopic cholecystectomy | IPG508 | | |
Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism | TA327 | | |
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment | DG16 | | |
Telemetric adjustable pulmonary artery banding for pulmonary hypertension in infants with congenital heart defects | IPG505 | | |
Insertion of an annular disc implant at lumbar discectomy | IPG506 | | |
Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula | IPG507 | | |
Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy | TA323 | | |
Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block | TA324 | | |
Nalmefene for reducing alcohol consumption in people with alcohol dependence | TA325 | | |
Imatinib for the adjuvant treatment of gastrointestinal stromal tumours | TA326 | | |
The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injury | MTG21 | | |
Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block | TA88 | | |
Gallstone disease: diagnosis and management | CG188 | | |
Oral health: local authorities and partners | PH55 | | |
Dabrafenib for treating unresectable or metastatic BRAF V600 mutation‑positive melanoma | TA321 | | |
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence | CG115 | | |
Combined endoscopic and laparoscopic removal of colonic polyps | IPG503 | | |
Drug allergy: diagnosis and management | CG183 | | |
Total prosthetic replacement of the temporomandibular joint | IPG500 | | |
Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis | TA320 | | |
Minimally invasive video-assisted thyroidectomy | IPG499 | | |
Minimally invasive video‑assisted parathyroidectomy | IPG501 | | |
Assessing motility of the gastrointestinal tract using a wireless capsule | IPG502 | | |
Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) | DG13 | | |
Endoscopic radiofrequency ablation for Barrett's oesophagus with low‑grade dysplasia or no dysplasia | IPG496 | | |
Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus | IPG497 | | |
Powered microdebrider turbinoplasty for inferior turbinate hypertrophy | IPG498 | | |
Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen | TA316 | | |
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes | TA317 | | |
Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma | TA319 | | |
Safe staffing for nursing in adult inpatient wards in acute hospitals | SG1 | | |
Endoscopic saphenous vein harvest for coronary artery bypass grafting | IPG494 | | |
Radiofrequency tissue reduction for turbinate hypertrophy | IPG495 | | |
The geko device for reducing the risk of venous thromboembolism | MTG19 | | |
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure | TA314 | | |
Canagliflozin in combination therapy for treating type 2 diabetes | TA315 | | |
Teriflunomide for treating relapsing–remitting multiple sclerosis | TA303 | | |
Gastroelectrical stimulation for gastroparesis | IPG489 | | |
Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb | IPG487 | | |
Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee | IPG493 | | |
Pressure ulcers: prevention and management | CG179 | | |
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer | TA310 | | |
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation | TA311 | | |
Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | DG12 | | |
Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults | IPG482 | | |
Insertion of a magnetic bead band for faecal incontinence | IPG483 | | |
Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancy | IPG484 | | |
Faecal microbiota transplant for recurrent Clostridium difficile infection | IPG485 | | |
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis | TA308 | | |
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy | TA307 | | |
Managing medicines in care homes | SC1 | | |
Psychosis and schizophrenia in adults: prevention and management | CG178 | | |
Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma | IPG478 | | |
Domestic violence and abuse: multi-agency working | PH50 | | |
Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip | TA304 | | |
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion | TA305 | | |
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma | TA306 | | |
Optical coherence tomography to guide percutaneous coronary intervention | IPG481 | | |
Endoscopic thoracic sympathectomy for primary facial blushing | IPG480 | | |
Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia | IPG475 | | |
Transcranial magnetic stimulation for treating and preventing migraine | IPG477 | | |
Arthroscopic trochleoplasty for patellar instability | IPG474 | | |
Radiofrequency ablation of the soft palate for snoring | IPG476 | | |
Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events | IPG472 | | |
Uterine artery embolisation for treating adenomyosis | IPG473 | | |
Negative pressure wound therapy for the open abdomen | IPG467 | | |
Phrenic nerve transfer in brachial plexus injury | IPG468 | | |
Implantation of a duodenal–jejunal bypass sleeve for managing obesity | IPG471 | | |
Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people | TA300 | | |
Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal) | TA302 | | |
Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C | TA106 | | |
Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C | TA75 | | |
Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel | DG11 | | |
Photochemical corneal collagen cross‑linkage using riboflavin and ultraviolet A for keratoconus and keratectasia | IPG466 | | |
Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease | IPG461 | | |
Translaryngeal tracheostomy | IPG462 | | |
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer | DG9 | | |
Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer | DG8 | | |
Pazopanib for the first-line treatment of advanced renal cell carcinoma | TA215 | | |
Varicose veins: diagnosis and management | CG168 | | |
Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder | TA292 | | |
Aflibercept solution for injection for treating wet age‑related macular degeneration | TA294 | | |
Insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction | IPG457 | | |
Selective internal radiation therapy for primary hepatocellular carcinoma | IPG460 | | |
Insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction | IPG449 | | |
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism | TA287 | | |
Mirabegron for treating symptoms of overactive bladder | TA290 | | |
Falls in older people: assessing risk and prevention | CG161 | | |
Social anxiety disorder: recognition, assessment and treatment | CG159 | | |
Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer | TA284 | | |
Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer | TA285 | | |
Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal) | TA286 | | |
Occipital nerve stimulation for intractable chronic migraine | IPG452 | | |
Corneal inlay implantation for correction of presbyopia | IPG455 | | |
Omalizumab for treating severe persistent allergic asthma | TA278 | | |
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures | TA279 | | |
Antisocial personality disorder: prevention and management | CG77 | | |
Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma | IPG446 | | |
Insertion of endobronchial valves for persistent air leaks | IPG448 | | |
Percutaneous electrical nerve stimulation for refractory neuropathic pain | IPG450 | | |
Peripheral nerve-field stimulation for chronic low back pain | IPG451 | | |
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis | TA276 | | |
Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) | TA277 | | |
Irreversible electroporation for treating primary lung cancer and metastases in the lung | IPG441 | | |
Irreversible electroporation for treating renal cancer | IPG443 | | |
Irreversible electroporation for treating liver metastases | IPG445 | | |
Ultrasound-guided foam sclerotherapy for varicose veins | IPG440 | | |
Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction | IPG436 | | |
Autologous blood injection for plantar fasciitis | IPG437 | | |
Autologous blood injection for tendinopathy | IPG438 | | |
Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy | IPG439 | | |
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract | TA272 | | |
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal) | TA273 | | |
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma | TA268 | | |
Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal) | TA270 | | |
Dronedarone for the treatment of non-permanent atrial fibrillation | TA197 | | |
Mannitol dry powder for inhalation for treating cystic fibrosis | TA266 | | |
Ivabradine for treating chronic heart failure | TA267 | | |
Laparoscopic gastric plication for the treatment of severe obesity | IPG432 | | |
Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease | IPG433 | | |
Radiofrequency cold ablation for respiratory papillomatosis | IPG434 | | |
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M | DG6 | | |
Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours | TA265 | | |
Alteplase for treating acute ischaemic stroke | TA264 | | |
Neutropenic sepsis: prevention and management in people with cancer | CG151 | | |
SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver | DG5 | | |
Mega Soft Patient Return Electrode for use during monopolar electrosurgery | MTG11 | | |
Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer | TA263 | | |
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism | TA261 | | |
Endovascular stent insertion for intracranial atherosclerotic disease | IPG429 | | |
Partial replacement of the meniscus of the knee using a biodegradable scaffold | IPG430 | | |
Sickle cell disease: managing acute painful episodes in hospital | CG143 | | |
Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2 | TA257 | | |
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer | TA258 | | |
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine | TA260 | | |
Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation | IPG427 | | |
Focal therapy using cryoablation for localised prostate cancer | IPG423 | | |
Micropressure therapy for refractory Ménière's disease | IPG426 | | |
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis | TA254 | | |
Incisionless otoplasty | IPG422 | | |
Pharmalgen for the treatment of bee and wasp venom allergy | TA246 | | |
Tocilizumab for the treatment of rheumatoid arthritis | TA247 | | |
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy | TA242 | | |
Rituximab for the first-line treatment of stage III-IV follicular lymphoma | TA243 | | |
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults | TA245 | | |
Breast reconstruction using lipomodelling after breast cancer treatment | IPG417 | | |
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer | TA118 | | |
Epiretinal brachytherapy for wet age-related macular degeneration | IPG415 | | |
Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services | CG136 | | |
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis | TA238 | | |
Fulvestrant for the treatment of locally advanced or metastatic breast cancer | TA239 | | |
Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants | IPG412 | | |
Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids | IPG413 | | |
Single-port laparoscopic nephrectomy | IPG414 | | |
Healthcare-associated infections: prevention and control | PH36 | | |
The EOS 2D/3D imaging system | DG1 | | |
Ticagrelor for the treatment of acute coronary syndromes | TA236 | | |
Mifamurtide for the treatment of osteosarcoma | TA235 | | |
Arthroscopic femoro–acetabular surgery for hip impingement syndrome | IPG408 | | |
Minimally invasive oesophagectomy | IPG407 | | |
Laparoscopic cryotherapy for renal cancer | IPG405 | | |
Percutaneous cryotherapy for renal cancer | IPG402 | | |
Open femoro–acetabular surgery for hip impingement syndrome | IPG403 | | |
Bortezomib and thalidomide for the first‑line treatment of multiple myeloma | TA228 | | |
Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion | TA229 | | |
Agomelatine for the treatment of major depressive episodes (terminated appraisal) | TA231 | | |
Ambulight PDT for the treatment of non-melanoma skin cancer | MTG6 | | |
The MIST Therapy system for the promotion of wound healing | MTG5 | | |
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction | TA73 | | |
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer | TA227 | | |
Endoscopic radical inguinal lymphadenectomy | IPG398 | | |
Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism | IPG400 | | |
Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs | TA225 | | |
Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma | TA226 | | |
Endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence | IPG393 | | |
Percutaneous tibial nerve stimulation for faecal incontinence | IPG395 | | |
Trabeculotomy ab interno for open angle glaucoma | IPG397 | | |
Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease | TA223 | | |
Carotid artery stent placement for symptomatic extracranial carotid stenosis | IPG389 | | |
Endovascular stent-grafting of popliteal aneurysms | IPG390 | | |
Extracorporeal membrane oxygenation for severe acute respiratory failure in adults | IPG391 | | |
Stent insertion for bleeding oesophageal varices | IPG392 | | |
Golimumab for the treatment of psoriatic arthritis | TA220 | | |
Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings | CG120 | | |
Hand allotransplantation | IPG383 | | |
Percutaneous retroperitoneal endoscopic necrosectomy | IPG384 | | |
Laser correction of refractive error following non-refractive ophthalmic surgery | IPG385 | | |
Deep brain stimulation for intractable trigeminal autonomic cephalalgias | IPG381 | | |
Deep brain stimulation for refractory chronic pain syndromes (excluding headache) | IPG382 | | |
Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia | TA218 | | |
Food allergy in under 19s: assessment and diagnosis | CG116 | | |
Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices | IPG380 | | |
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer | TA214 | | |
Bendamustine for the first-line treatment of chronic lymphocytic leukaemia | TA216 | | |
Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome | IPG376 | | |
Off-pump coronary artery bypass grafting | IPG377 | | |
Percutaneous laser coronary angioplasty | IPG378 | | |
Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years | TA213 | | |
Thoracoscopic repair of congenital diaphragmatic hernia in neonates | IPG379 | | |
Distal iliotibial band lengthening for refractory greater trochanteric pain syndrome | IPG375 | | |
Sedation in under 19s: using sedation for diagnostic and therapeutic procedures | CG112 | | |
Cryotherapy for the treatment of liver metastases | IPG369 | | |
Percutaneous closure of patent foramen ovale for recurrent migraine | IPG370 | | |
Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers | IPG371 | | |
Percutaneous radiofrequency ablation for primary or secondary lung cancers | IPG372 | | |
Selective dorsal rhizotomy for spasticity in cerebral palsy | IPG373 | | |
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events | TA210 | | |
Prucalopride for the treatment of chronic constipation in women | TA211 | | |
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer | TA212 | | |
Interspinous distraction procedures for lumbar spinal stenosis causing neurogenic claudication | IPG365 | | |
Non-rigid stabilisation techniques for the treatment of low back pain | IPG366 | | |
Uterine artery embolisation for fibroids | IPG367 | | |
Unintentional injuries in the home: interventions for under 15s | PH30 | | |
Trastuzumab for the treatment of HER2-positive metastatic gastric cancer | TA208 | | |
Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours | TA209 | | |
Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours | TA86 | | |
Bedwetting in under 19s | CG111 | | |
Endoscopic mucosal resection and endoscopic submucosal dissection of non-ampullary duodenal lesions | IPG359 | | |
Endoscopic submucosal dissection of gastric lesions | IPG360 | | |
Insertion of metal rib reinforcements to stabilise a flail chest wall | IPG361 | | |
Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome | IPG362 | | |
Minimally invasive total hip replacement | IPG363 | | |
Transperineal template biopsy and mapping of the prostate | IPG364 | | |
Denosumab for the prevention of osteoporotic fractures in postmenopausal women | TA204 | | |
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal) | TA206 | | |
Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal) | TA207 | | |
Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors | CG110 | | |
Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia | IPG355 | | |
Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer | IPG356 | | |
Percutaneous intradiscal laser ablation in the lumbar spine | IPG357 | | |
Phototherapeutic laser keratectomy for corneal surface irregularities | IPG358 | | |
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C | TA200 | | |
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor | TA195 | | |
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis | TA199 | | |
Percutaneous mitral valve annuloplasty | IPG352 | | |
Percutaneous radiofrequency ablation for renal cancer | IPG353 | | |
Shoulder resurfacing arthroplasty | IPG354 | | |
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia | TA193 | | |
Capecitabine for the treatment of advanced gastric cancer | TA191 | | |
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer | TA192 | | |
Stapled transanal rectal resection for obstructed defaecation syndrome | IPG351 | | |
Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism | IPG349 | | |
Photodynamic therapy for Barrett's oesophagus | IPG350 | | |
Alcohol-use disorders: prevention | PH24 | | |
Epithelial radiofrequency ablation for Barrett's oesophagus | IPG344 | | |
Mini-incision surgery for total knee replacement | IPG345 | | |
Therapeutic hypothermia with intracorporeal temperature monitoring for hypoxic perinatal brain injury | IPG347 | | |
Human growth hormone (somatropin) for the treatment of growth failure in children | TA188 | | |
Improving outcomes for people with skin tumours including melanoma | CSG8 | | |
Limited macular translocation for wet age-related macular degeneration | IPG339 | | |
Macular translocation with 360° retinotomy for wet age-related macular degeneration | IPG340 | | |
Prosthetic intervertebral disc replacement in the cervical spine | IPG341 | | |
Haemorrhoidal artery ligation | IPG342 | | |
Infliximab and adalimumab for the treatment of Crohn's disease | TA187 | | |
Arteriovenous crossing sheathotomy for branch retinal vein occlusion | IPG334 | | |
Endoscopic submucosal dissection of lower gastrointestinal lesions | IPG335 | | |
Transcatheter endovascular closure of perimembranous ventricular septal defect | IPG336 | | |
Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions | IPG337 | | |
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes | TA47 | | |
Donor milk banks: service operation | CG93 | | |
Surgical correction of hallux valgus using minimal access techniques | IPG332 | | |
Therapeutic endoscopic division of epidural adhesions | IPG333 | | |
Radiofrequency ablation for colorectal liver metastases | IPG327 | | |
Suction diathermy adenoidectomy | IPG328 | | |
Balloon catheter insertion for Bartholin's cyst or abscess | IPG323 | | |
Electrocautery cutting balloon treatment for pelviureteric junction obstruction | IPG324 | | |
Endopyelotomy for pelviureteric junction obstruction | IPG325 | | |
Laparoscopic augmentation cystoplasty (including clam cystoplasty) | IPG326 | | |
Topotecan for the treatment of relapsed small-cell lung cancer | TA184 | | |
Depression in adults with a chronic physical health problem: recognition and management | CG91 | | |
Topotecan for the treatment of recurrent and stage IVB cervical cancer | TA183 | | |
Guidance on the use of electroconvulsive therapy | TA59 | | |
Extracorporeal albumin dialysis for acute liver failure | IPG316 | | |
Individually magnetic resonance imaging-designed unicompartmental interpositional implant insertion for osteoarthritis of the knee | IPG317 | | |
Sunitinib for the treatment of gastrointestinal stromal tumours | TA179 | | |
Pemetrexed for the first-line treatment of non-small-cell lung cancer | TA181 | | |
Placement of pectus bar for pectus excavatum (also known as MIRPE or the Nuss procedure) | IPG310 | | |
Extracorporeal shockwave therapy for refractory plantar fasciitis | IPG311 | | |
Extracorporeal shockwave therapy for refractory tennis elbow | IPG313 | | |
Alitretinoin for the treatment of severe chronic hand eczema | TA177 | | |
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma | TA178 | | |
Prosthetic intervertebral disc replacement in the lumbar spine | IPG306 | | |
Image-guided radiofrequency excision biopsy of breast lesions | IPG308 | | |
Sinus tarsi implant insertion for mobile flatfoot | IPG305 | | |
Tenofovir disoproxil for the treatment of chronic hepatitis B | TA173 | | |
Rituximab for the first-line treatment of chronic lymphocytic leukaemia | TA174 | | |
Percutaneous endoscopic laser cervical discectomy | IPG303 | | |
Corneal endothelial transplantation | IPG304 | | |
Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) | IPG299 | | |
Transmyocardial laser revascularisation for refractory angina pectoris | IPG301 | | |
Percutaneous laser revascularisation for refractory angina pectoris | IPG302 | | |
Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management | CG84 | | |
Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD) | IPG297 | | |
Ex-vivo hepatic resection and reimplantation for liver cancer | IPG298 | | |
Endoscopic mastectomy and endoscopic wide local excision for breast cancer | IPG296 | | |
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults | TA170 | | |
Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation | IPG294 | | |
Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia | IPG295 | | |
Rehabilitation after critical illness in adults | CG83 | | |
Photodynamic therapy for brain tumours | IPG290 | | |
Implantation of an opaque intraocular lens for intractable double vision | IPG293 | | |
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma | TA169 | | |
Extracorporeal photopheresis for Crohn's disease | IPG288 | | |
Intraocular lens insertion for correction of refractive error, with preservation of the natural lens | IPG289 | | |
Laparoscopic cystectomy | IPG287 | | |
Amantadine, oseltamivir and zanamivir for the treatment of influenza | TA168 | | |
Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence | CG76 | | |
Borderline personality disorder: recognition and management | CG78 | | |
Functional electrical stimulation for drop foot of central neurological origin | IPG278 | | |
Ultrasound-guided regional nerve block | IPG285 | | |
Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation | IPG286 | | |
Machine perfusion systems and cold static storage of kidneys from deceased donors | TA165 | | |
Infliximab for acute exacerbations of ulcerative colitis | TA163 | | |
Laparoscopic prostatectomy for benign prostatic obstruction | IPG275 | | |
Transabdominal artificial bowel sphincter implantation for faecal incontinence | IPG276 | | |
Mental wellbeing in over 65s: occupational therapy and physical activity interventions | PH16 | | |
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin | TA159 | | |
Balloon catheter dilation of paranasal sinus ostia for chronic sinusitis | IPG273 | | |
Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy | IPG274 | | |
Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults | TA157 | | |
Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza | TA158 | | |
Total wrist replacement | IPG271 | | |
Routine antenatal anti-D prophylaxis for women who are rhesus D negative | TA156 | | |
Entecavir for the treatment of chronic hepatitis B | TA153 | | |
Telbivudine for the treatment of chronic hepatitis B | TA154 | | |
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision | IPG268 | | |
Laparoscopic gastrectomy for cancer | IPG269 | | |
Direct skeletal fixation of limb or digit prostheses using intraosseous transcutaneous implants | IPG270 | | |
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus | TA151 | | |
Lumbar infusion test for the investigation of normal pressure hydrocephalus | IPG263 | | |
Implantation of multifocal (non-accommodative) intraocular lenses during cataract surgery | IPG264 | | |
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal) | TA148 | | |
Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal) | TA149 | | |
Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck | TA145 | | |
Adalimumab for the treatment of adults with psoriasis | TA146 | | |
Endoaortic balloon occlusion for cardiac surgery | IPG261 | | |
Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy | IPG258 | | |
Interstitial photodynamic therapy for malignant parotid tumours | IPG259 | | |
Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus | IPG257 | | |
Intraoperative nerve monitoring during thyroid surgery | IPG255 | | |
Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over | TA138 | | |
Laser-assisted cerebral vascular anastomosis without temporary arterial occlusion | IPG252 | | |
Laparoscopic mobilisation of the greater omentum for breast reconstruction | IPG253 | | |
Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses | IPG254 | | |
Structural neuroimaging in first-episode psychosis | TA136 | | |
Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma | TA137 | | |
Ultrasound-guided catheterisation of the epidural space | IPG249 | | |
Infliximab for the treatment of adults with psoriasis | TA134 | | |
Pemetrexed for the treatment of malignant pleural mesothelioma | TA135 | | |
Thoracoscopically assisted mitral valve surgery | IPG245 | | |
Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates | IPG246 | | |
Thoracoscopic excision of mediastinal parathyroid tumours | IPG247 | | |
Thoracoscopic aortopexy for severe primary tracheomalacia | IPG243 | | |
Grenz rays therapy for inflammatory skin conditions | IPG236 | | |
Mini/micro screw implantation for orthodontic anchorage | IPG238 | | |
Laparoscopic techniques for hysterectomy | IPG239 | | |
Soft-palate implants for simple snoring | IPG240 | | |
Soft-palate implants for obstructive sleep apnoea | IPG241 | | |
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years | TA131 | | |
Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain | IPG234 | | |
Bortezomib monotherapy for relapsed multiple myeloma | TA129 | | |
Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children | IPG232 | | |
Stapled haemorrhoidopexy for the treatment of haemorrhoids | TA128 | | |
Laparoscopic repair of abdominal aortic aneurysm | IPG229 | | |
Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis | IPG230 | | |
Pemetrexed for the treatment of non-small-cell lung cancer | TA124 | | |
Therapeutic percutaneous image-guided aspiration of spinal cysts | IPG223 | | |
Acutely ill adults in hospital: recognising and responding to deterioration | CG50 | | |
Drug misuse in over 16s: opioid detoxification | CG52 | | |
Drug misuse in over 16s: psychosocial interventions | CG51 | | |
Laparoscopic deroofing of simple renal cysts | IPG226 | | |
Corneal implants for keratoconus | IPG227 | | |
Corneal implants for the correction of refractive error | IPG225 | | |
Varenicline for smoking cessation | TA123 | | |
Faecal incontinence in adults: management | CG49 | | |
Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease | IPG222 | | |
Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma | TA121 | | |
Therapeutic sialendoscopy | IPG218 | | |
Lower limb deep vein valve reconstruction for chronic deep venous incompetence | IPG219 | | |
Tissue-cultured limbal stem cell allograft transplantation for regrowth of corneal epithelium | IPG216 | | |
Laparoscopic nephrolithotomy and pyelolithotomy | IPG212 | | |
Microwave ablation of hepatocellular carcinoma | IPG214 | | |
Radiofrequency-assisted liver resection | IPG211 | | |
Laparoscopic insertion of peritoneal dialysis catheter | IPG208 | | |
Implantation of accommodating intraocular lenses for cataract | IPG209 | | |
Injectable bulking agents for faecal incontinence | IPG210 | | |
Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia | TA119 | | |
Laparoscopic distal pancreatectomy | IPG204 | | |
Fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction | IPG205 | | |
Palliative photodynamic therapy for advanced oesophageal cancer | IPG206 | | |
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy | TA117 | | |
Methadone and buprenorphine for the management of opioid dependence | TA114 | | |
Naltrexone for the management of opioid dependence | TA115 | | |
Gemcitabine for the treatment of metastatic breast cancer | TA116 | | |
Intrauterine laser ablation of placental vessels for the treatment of twin-to-twin transfusion syndrome | IPG198 | | |
Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome | IPG199 | | |
Photodynamic therapy for early-stage oesophageal cancer | IPG200 | | |
Fetal vesico–amniotic shunt for lower urinary tract outflow obstruction | IPG202 | | |
Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) | IPG192 | | |
Laparoscopic radical prostatectomy | IPG193 | | |
Insertion of pleuro–amniotic shunt for fetal pleural effusion | IPG190 | | |
Deep brain stimulation for tremor and dystonia (excluding Parkinson's disease) | IPG188 | | |
Laparoscopic surgery for colorectal cancer | TA105 | | |
High-intensity focused ultrasound for atrial fibrillation in association with other cardiac surgery | IPG184 | | |
Tonsillectomy using laser | IPG186 | | |
Catheterless oesophageal pH monitoring | IPG187 | | |
Etanercept and efalizumab for the treatment of adults with psoriasis | TA103 | | |
Improving outcomes for people with brain and other central nervous system tumours | CSG10 | | |
Percutaneous cementoplasty for palliative treatment of bony malignancies | IPG179 | | |
Percutaneous laser therapy for fetal tumours | IPG180 | | |
Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery | IPG177 | | |
Tonsillectomy using ultrasonic scalpel | IPG178 | | |
Docetaxel for the treatment of hormone-refractory metastatic prostate cancer | TA101 | | |
Living-donor lung transplantation for end-stage lung disease | IPG170 | | |
Laparoscopic helium plasma coagulation for the treatment of endometriosis | IPG171 | | |
High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer | IPG174 | | |
Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum | IPG176 | | |
Percutaneous radiofrequency ablation for atrial fibrillation | IPG168 | | |
Balloon kyphoplasty for vertebral compression fractures | IPG166 | | |
Retrograde urethral sphincterometry | IPG167 | | |
Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer | TA100 | | |
Laparoscopic retroperitoneal lymph node dissection for testicular cancer | IPG158 | | |
Stimulated graciloplasty for faecal incontinence | IPG159 | | |
High dose rate brachytherapy for carcinoma of the cervix | IPG160 | | |
Percutaneous endoscopic colostomy | IPG161 | | |
Stent-graft placement in abdominal aortic aneurysm | IPG163 | | |
Photorefractive (laser) surgery for the correction of refractive errors | IPG164 | | |
Endometrial cryotherapy for menorrhagia | IPG157 | | |
Improving outcomes for people with sarcoma | CSG9 | | |
Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions) | IPG155 | | |
Image-guided vacuum-assisted excision biopsy of benign breast lesions | IPG156 | | |
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B | TA96 | | |
Laparoscopic partial nephrectomy | IPG151 | | |
Foker technique for long-gap oesophageal atresia | IPG153 | | |
Retrobulbar irradiation for thyroid eye disease | IPG148 | | |
Division of ankyloglossia (tongue-tie) for breastfeeding | IPG149 | | |
Electrosurgery (diathermy and coblation) for tonsillectomy | IPG150 | | |
Direct C1 lateral mass screw for cervical spine stabilisation | IPG146 | | |
Endoscopic axillary lymph node retrieval for breast cancer | IPG147 | | |
Obsessive-compulsive disorder and body dysmorphic disorder: treatment | CG31 | | |
Metatarsophalangeal joint replacement of the hallux | IPG140 | | |
Automated percutaneous mechanical lumbar discectomy | IPG141 | | |
Cryotherapy for malignant endobronchial obstruction | IPG142 | | |
Intraoperative blood cell salvage in obstetrics | IPG144 | | |
Photodynamic therapy for localised inoperable endobronchial cancer | IPG137 | | |
Cryotherapy as a primary treatment for prostate cancer | IPG145 | | |
Intramural urethral bulking procedures for stress urinary incontinence in women | IPG138 | | |
Improving outcomes in children and young people with cancer | CSG7 | | |
Laparoscopic nephrectomy (including nephroureterectomy) | IPG136 | | |
Low dose rate brachytherapy for localised prostate cancer | IPG132 | | |
Photodynamic therapy for bile duct cancer | IPG134 | | |
Laparoscopic liver resection | IPG135 | | |
HealOzone for the treatment of tooth decay (occlusal pit and fissure caries and root caries) | TA92 | | |
Leukapheresis for inflammatory bowel disease | IPG126 | | |
Collagen injection for vocal cord augmentation | IPG130 | | |
Endovascular stent–graft placement in thoracic aortic aneurysms and dissections | IPG127 | | |
Interstitial laser therapy for fibroadenomas of the breast | IPG131 | | |
Totally endoscopic robotically assisted coronary artery bypass grafting | IPG128 | | |
Computed tomographic colonography (virtual colonoscopy) | IPG129 | | |
Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery | IPG121 | | |
Microwave ablation for atrial fibrillation in association with other cardiac surgery | IPG122 | | |
Cryoablation for atrial fibrillation in association with other cardiac surgery | IPG123 | | |
Cryotherapy for recurrent prostate cancer | IPG119 | | |
Guidance on the use of paclitaxel in the treatment of ovarian cancer | TA55 | | |
High-intensity focused ultrasound for prostate cancer | IPG118 | | |
Artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis | IPG110 | | |
Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis | IPG111 | | |
Endoscopic dacryocystorhinostomy | IPG113 | | |
Lung volume reduction surgery for advanced emphysema | IPG114 | | |
Coil embolisation of ruptured intracranial aneurysms | IPG106 | | |
Auditory brain stem implants | IPG108 | | |
Coil embolisation of unruptured intracranial aneurysms | IPG105 | | |
Wireless capsule endoscopy for investigation of the small bowel | IPG101 | | |
Improving outcomes in head and neck cancers | CSG6 | | |
Sacral nerve stimulation for faecal incontinence | IPG99 | | |
Dental checks: intervals between oral health reviews | CG19 | | |
Radiofrequency valvotomy for pulmonary atresia | IPG95 | | |
Endovascular closure of atrial septal defect | IPG96 | | |
Endovascular closure of patent ductus arteriosus | IPG97 | | |
Intraoperative fluorescence angiography for the evaluation of coronary artery bypass graft patency | IPG98 | | |
Interstitial laser therapy for breast cancer | IPG89 | | |
Intralesional photocoagulation of subcutaneous congenital vascular disorders | IPG90 | | |
Laparoscopic surgery for inguinal hernia repair | TA83 | | |
Selective peripheral denervation for cervical dystonia | IPG80 | | |
Supraorbital minicraniotomy for intracranial aneurysm | IPG84 | | |
Endovascular atrial septostomy | IPG86 | | |
Photodynamic therapy for advanced bronchial carcinoma | IPG87 | | |
Tacrolimus and pimecrolimus for atopic eczema | TA82 | | |
Frequency of application of topical corticosteroids for atopic eczema | TA81 | | |
Balloon dilatation of systemic to pulmonary arterial shunts in children | IPG77 | | |
Balloon valvuloplasty for aortic valve stenosis in adults and children | IPG78 | | |
Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children | IPG76 | | |
Scleral expansion surgery for presbyopia | IPG70 | | |
Balloon angioplasty of pulmonary vein stenosis in infants | IPG75 | | |
Stent placement for vena caval obstruction | IPG79 | | |
Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and children | IPG74 | | |
Fallopian tube recanalisation by guidewire | IPG71 | | |
Insertion of hydrogel keratoprosthesis | IPG69 | | |
Lumbar subcutaneous shunt | IPG68 | | |
Balloon dilatation of pulmonary valve stenosis | IPG67 | | |
Artificial anal sphincter implantation | IPG66 | | |
Subthalamotomy for Parkinson's disease | IPG65 | | |
Sacral nerve stimulation for urge incontinence and urgency-frequency | IPG64 | | |
Falloposcopy with coaxial catheter | IPG62 | | |
Laser sheath removal of pacing leads | IPG63 | | |
Thrombin injections for pseudoaneurysms | IPG60 | | |
Laparoscopic live donor simple nephrectomy | IPG57 | | |
Transpupillary thermotherapy for age-related macular degeneration | IPG58 | | |
Subfascial endoscopic perforator vein surgery | IPG59 | | |
Percutaneous endoscopic laser thoracic discectomy | IPG61 | | |
Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) | IPG56 | | |
Endoscopic injection of bulking agents for gastro-oesophageal reflux disease | IPG55 | | |
Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia | TA77 | | |
Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding | TA78 | | |
Improving supportive and palliative care for adults with cancer | CSG4 | | |
Photodynamic endometrial ablation | IPG47 | | |
Vagus nerve stimulation for refractory epilepsy in children | IPG50 | | |
Radiotherapy for age-related macular degeneration | IPG49 | | |
Laparoscopic pyeloplasty | IPG46 | | |
Computed tomography-guided thermocoagulation of osteoid osteoma | IPG53 | | |
Endovenous laser treatment of the long saphenous vein | IPG52 | | |
Cyanoacrylate instillation for occlusion of parotid sinuses | IPG42 | | |
Partial left ventriculectomy (the Batista procedure) | IPG41 | | |
Non-surgical reduction of the myocardial septum | IPG40 | | |
Needle fasciotomy for Dupuytren's contracture | IPG43 | | |
Transilluminated powered phlebectomy for varicose veins | IPG37 | | |
Extracorporeal membrane oxygenation (ECMO) in postneonatal children | IPG38 | | |
Pre-hospital initiation of fluid replacement therapy in trauma | TA74 | | |
Circular stapled haemorrhoidectomy | IPG34 | | |
Endoscopic laser foraminoplasty | IPG31 | | |
Laparo-endogastric surgery | IPG25 | | |
Extracorporeal shockwave therapy for Peyronie's disease | IPG29 | | |
Endoscopic transsphenoidal pituitary adenoma resection | IPG32 | | |
Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids | IPG30 | | |
Holmium laser prostatectomy | IPG17 | | |
Bone-anchored cystourethropexy | IPG18 | | |
Deep brain stimulation for Parkinson's disease | IPG19 | | |
Endoscopic stapling of pharyngeal pouch | IPG22 | | |
Laparoscopic laser myomectomy | IPG23 | | |
Transurethral electrovaporisation of the prostate | IPG14 | | |
Guidance on the use of liquid-based cytology for cervical screening | TA69 | | |
Percutaneous vertebroplasty | IPG12 | | |
Radiofrequency ablation of varicose veins | IPG8 | | |
Human growth hormone (somatropin) in adults with growth hormone deficiency | TA64 | | |
Radiofrequency ablation of hepatocellular carcinoma | IPG2 | | |
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer | TA61 | | |
Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction | TA52 | | |
Guidance on the use of ultrasound locating devices for placing central venous catheters | TA49 | | |
Improving outcomes in urological cancers | CSG2 | | |
Improving outcomes in breast cancer | CSG1 | | |
Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years) | TA38 | | |
Guidance on the use of trastuzumab for the treatment of advanced breast cancer | TA34 | | |
Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia | TA29 | | |
Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease | TA20 | | |
Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma | TA10 | | |
Guidance on the extraction of wisdom teeth | TA1 | | |